0 likes | 12 Views
The global orthobiologics market is projected to grow at a CAGR of ~6% by attaining robust revenue during the forecast period, i.e., 2023 u2013 2033. Increment in the sales of orthopedic devices is anticipated to propel the growth of the market during the forecast period. In 2022, the orthopedic device segment was estimated to hit around USD 40 billion. Additionally, rising cases of orthopedic injuries are further estimated to propel the market growth over the forecast period. For instance, it observed that about 6 million orthopedic surgeries are performed annually.
E N D